Observational study for evaluation of quality of life [QOL] in patients under treatment for B-CLL.
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2013
At a glance
- Drugs Alemtuzumab; Fludarabine
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- Acronyms Vitalis
- Sponsors Sanofi
- 07 Jul 2009 Alemtuzumab, fludarabine added as drug descriptors as reported by ClinicalTrials.gov.
- 07 Jul 2009 Bayer Company added as trial sponsor and affiliate as reported by ClinicalTrials.gov.
- 08 Apr 2009 Actual patient number (300) added as reported by ClinicalTrials.gov.